Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Stürzebecher

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Deutsches Arzteblatt International|November 24, 2022
Misadministration of MethotrexateMichael Deters, Anne Stürzebecher
Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|May 16, 2022
Exposures to psycholeptics, psychoanaleptics, and cardiovascular drugs reported to the PIC erfurt during heat waves from 2003 to 2018Michael Deters, Mandy Gollmann, Friederike Rau, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|July 20, 2006
New substrate analogue inhibitors of factor Xa containing 4-amidinobenzylamide as P1 residue: part 1Andrea Schweinitz, Anne Stürzebecher, Uta Stürzebecher, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 3, 2018
[Substance Abuse Poisoning Reported to the Poisons Information Centre Erfurt from 2002 to 2016]Mandy Gollmann, Germaine Frimlova, Simone Just, et al.
International Journal of Oncology|September 6, 2005
In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinomaDiana Förbs, Stefan Thiel, Maria C Stella, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2007
From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3Daniel Dönnecke, Andrea Schweinitz, Anne Stürzebecher, et al.
Chemmedchem|June 2, 2007
Highly potent and selective substrate analogue factor Xa inhibitors containing D-homophenylalanine analogues as P3 residue: part 2Anne Stürzebecher, Daniel Dönnecke, Andrea Schweinitz, et al.
Journal of Medicinal Chemistry|July 11, 2006
Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptaseTorsten Steinmetzer, Andrea Schweinitz, Anne Stürzebecher, et al.
The Journal of Biological Chemistry|May 20, 2004
Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agentsAndrea Schweinitz, Torsten Steinmetzer, Ingo J Banke, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Deutsches Arzteblatt International|November 24, 2022
Misadministration of MethotrexateMichael Deters, Anne Stürzebecher
Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|May 16, 2022
Exposures to psycholeptics, psychoanaleptics, and cardiovascular drugs reported to the PIC erfurt during heat waves from 2003 to 2018Michael Deters, Mandy Gollmann, Friederike Rau, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|July 20, 2006
New substrate analogue inhibitors of factor Xa containing 4-amidinobenzylamide as P1 residue: part 1Andrea Schweinitz, Anne Stürzebecher, Uta Stürzebecher, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 3, 2018
[Substance Abuse Poisoning Reported to the Poisons Information Centre Erfurt from 2002 to 2016]Mandy Gollmann, Germaine Frimlova, Simone Just, et al.
International Journal of Oncology|September 6, 2005
In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinomaDiana Förbs, Stefan Thiel, Maria C Stella, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2007
From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3Daniel Dönnecke, Andrea Schweinitz, Anne Stürzebecher, et al.
Chemmedchem|June 2, 2007
Highly potent and selective substrate analogue factor Xa inhibitors containing D-homophenylalanine analogues as P3 residue: part 2Anne Stürzebecher, Daniel Dönnecke, Andrea Schweinitz, et al.
Journal of Medicinal Chemistry|July 11, 2006
Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptaseTorsten Steinmetzer, Andrea Schweinitz, Anne Stürzebecher, et al.
The Journal of Biological Chemistry|May 20, 2004
Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agentsAndrea Schweinitz, Torsten Steinmetzer, Ingo J Banke, et al.
Pageof 1